Broadcast

The Science of Radiofrequency Renal Denervation

Stefan Tunev, Andrew SP Sharp

Watch time: 1h 12m 55s

Broadcast

Nocturnal Hypertension

Roland Asmar, , , et al

Watch time: 1h 9m 26s

About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

Cardiovascular Risk Management - Efficacy of Manidipine in Hypertension and Beyond

Citation:

European Cardiology 2008;4(1):69–74

Blood Pressure Control - The Role of Single-pill Combination Therapies

Citation:

European Cardiology 2009;5(1):52–5

Myocardial Perfusion Imaging from Echocardiography to SPECT, PET, CT, and MRI-Recent Advances and Applications

Citation:

European Cardiology 2010;6(1):32–6

Insights from the International Registry of Acute Aortic Dissection - What Have We Learned?

Citation:

European Cardiology 2008;4(1):79–82